Repeat cryoablation as a redo procedure for atrial fibrillation ablation: Is it a good choice?
Authors:
- Carlos Antonio Álvarez-OrtegaCÁCarlos Antonio Álvarez-Ortega
- César Rainer Solórzano GuillénCGCésar Rainer Solórzano Guillén
- Alberto Barrera CorderoACAlberto Barrera Cordero
- Jorge Enrique Toquero RamosJRJorge Enrique Toquero Ramos
- Jesús Daniel Martínez-AldayJMJesús Daniel Martínez-Alday
- Carlos Eugenio Grande MoralesCMCarlos Eugenio Grande Morales
- Arcadio García AlberolaAAArcadio García Alberola
- Luisa Pérez ÁlvarezLÁLuisa Pérez Álvarez
- Ángel Ferrero de Loma OsorioÁOÁngel Ferrero de Loma Osorio
- Julio Salvador Hernández AfonsoJAJulio Salvador Hernández Afonso
- Rocío Cózar LeónRLRocío Cózar León
Open Access
- 27 April 2024
- journal article
- research article
- Published by VM Media Group sp. z o.o in Cardiology Journal
- Vol. 31 (2) , 193-204
Abstract
Background: Ablation of atrial fibrillation (AF), both cryoablation ablation (CBA) and radiofrequency catheter ablation (RFCA), have demonstrated to be safe and effective. About 1 in 3 patients may face a redo due to recurrence and the best technique is unknown. The aim of this study is to assess the efficacy of CBA as a repeat procedure in patients with prior CBA or RFCA. Methods: A nation-wide CBA registry (RECABA) was analyzed and patients were compared who had previously undergone CBA (Prior-CB) or RFCA (Prior-RF). The primary endpoint was AF recurrence at 12 months after a 3-month blanking period. A survival analysis was performed, univariate and multivariate Cox models were also built. Results: Seventy-four patients were included. Thirty-three (44.6%) were in the Prior-CB group and 41 (55.4%) in the Prior-RF. There were more reconnected pulmonary veins in the Prior-RF than in Prior-CB group (40.4% vs.16.5%, p = 0.0001). The 12-month Kaplan–Meier estimate of freedom from AF recurrence after the blanking period was 61.0% (95% confidence interval [CI] 41.4–75.8%) in the Prior-CB, and 89.2% (95% CI 73.6–95.9%) in the Prior-RF group (p = 0.002). Multivariate Cox regression pointed Prior-CB as the sole independent predictor of AF recurrence, with an adjusted HR of 2.67 (95% CI 1.05–6.79). Conclusions: Repeat CBA shows higher rates of AF recurrences compared to CBA after a previous RFCA despite presenting less reconnected veins at the procedure. These data suggest that patients with AF recurrence after CBA may benefit from other ablation techniques after a recurrence. RECABA is registered at clinicaltrials.gov with the Unique Identifier NCT02785991. Background: Ablation of atrial fibrillation (AF), both cryoablation ablation (CBA) and radiofrequency catheter ablation (RFCA), have demonstrated to be safe and effective. About 1 in 3 patients may face a redo due to recurrence and the best technique is unknown. The aim of this study is to assess the efficacy of CBA as a repeat procedure in patients with prior CBA or RFCA. Methods: A nation-wide CBA registry (RECABA) was analyzed and patients were compared who had previously undergone CBA (Prior-CB) or RFCA (Prior-RF). The primary endpoint was AF recurrence at 12 months after a 3-month blanking period. A survival analysis was performed, univariate and multivariate Cox models were also built. Results: Seventy-four patients were included. Thirty-three (44.6%) were in the Prior-CB group and 41 (55.4%) in the Prior-RF. There were more reconnected pulmonary veins in the Prior-RF than in Prior-CB group (40.4% vs.16.5%, p = 0.0001). The 12-month Kaplan–Meier estimate of freedom from AF recurrence after the blanking period was 61.0% (95% confidence interval [CI] 41.4–75.8%) in the Prior-CB, and 89.2% (95% CI 73.6–95.9%) in the Prior-RF group (p = 0.002). Multivariate Cox regression pointed Prior-CB as the sole independent predictor of AF recurrence, with an adjusted HR of 2.67 (95% CI 1.05–6.79). Conclusions: Repeat CBA shows higher rates of AF recurrences compared to CBA after a previous RFCA despite presenting less reconnected veins at the procedure. These data suggest that patients with AF recurrence after CBA may benefit from other ablation techniques after a recurrence. RECABA is registered at clinicaltrials.gov with the Unique Identifier NCT02785991.Keywords
This publication has 29 references indexed in Scilit:
- Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial FibrillationNew England Journal of Medicine, 2016
- Procedural and biophysical indicators of durable pulmonary vein isolation during cryoballoon ablation of atrial fibrillationHeart Rhythm, 2016
- On the Quest for the Best FreezeCirculation: Arrhythmia and Electrophysiology, 2015
- Electrophysiological findings following pulmonary vein isolation using radiofrequency catheter guided by contact-force and second-generation cryoballoon: lessons from repeat ablation proceduresEP Europace, 2015
- Best practice guide for cryoballoon ablation in atrial fibrillation: The compilation experience of more than 3000 proceduresHeart Rhythm, 2015
- One-year clinical success of a ‘no-bonus’ freeze protocol using the second-generation 28 mm cryoballoon for pulmonary vein isolationEP Europace, 2015
- Cryoballoon Versus Radiofrequency for Pulmonary Vein Re‐Isolation After a Failed Initial Ablation Procedure in Patients with Paroxysmal Atrial FibrillationJournal of Cardiovascular Electrophysiology, 2012
- Recurrence of paroxysmal atrial fibrillation after cryoisolation of the pulmonary veins. Is a “redo” procedure using the cryoballoon useful?Journal of Interventional Cardiac Electrophysiology, 2012
- Long‐Term Outcome of Atrial Fibrillation Ablation: Impact and Predictors of Very Late RecurrenceJournal of Cardiovascular Electrophysiology, 2010
- Long‐Term Outcome Following Successful Pulmonary Vein Isolation: Pattern and Prediction of Very Late RecurrenceJournal of Cardiovascular Electrophysiology, 2008